World Orphan Drug Congress (WODC) Europe 2026

World Orphan Drug Congress (WODC) Europe 2026
By Nitin Goswami · Pharma Insights · 21 Oct 2026

Discover global developments in rare disease research, orphan drug development, advanced therapies, and pharmaceutical innovation at the World Orphan Drug Congress (WODC) Europe 2026.

Event Dates: 26–28 October 2026
Venue: RAI Amsterdam Convention Centre, Hall 10, Amsterdam, Netherlands

Explore IKRIS Pharma Network’s Exhibitor Profile →

About World Orphan Drug Congress (WODC) Europe 2026

The World Orphan Drug Congress (WODC) Europe brings together stakeholders involved in rare disease research, orphan drug development, clinical innovation, patient advocacy, and access to treatments for rare conditions.

The 2026 event in Amsterdam provides a platform for discussions around scientific progress, regulatory developments, market access, and collaboration across the rare disease ecosystem.

This event information page is published by The Indian Pharma, a pharmaceutical sourcing and export platform connected with IKRIS Pharma Network.

Event Highlights

  • Rare disease research and orphan drug development

  • Cell and gene therapy innovation

  • Precision medicine and genetic testing

  • Clinical development and real-world evidence

  • Market access, pricing, and reimbursement

  • Patient advocacy and rare disease policy

  • Pharmaceutical partnerships and industry networking

Key Areas of Focus

Orphan Drug Development

Explore industry discussions on the development of treatments for rare diseases, including scientific, clinical, and regulatory considerations.

Cell and Gene Therapies

Learn about developments in advanced therapy approaches and their role in rare disease research.

Clinical Research and Precision Medicine

Discover discussions covering clinical trials, genetic testing, real-world evidence, and personalised treatment approaches.

Market Access and Healthcare Policy

Understand industry discussions around reimbursement, health technology assessment, pricing, and patient access.

Global Pharmaceutical Collaboration

Explore opportunities for professional networking and knowledge exchange across the pharmaceutical and biotechnology sectors.

Who Should Follow WODC 2026?

The congress is relevant to professionals and organisations working across:

  • Pharmaceutical and biotechnology companies

  • Rare disease and orphan drug research

  • Clinical research and drug development

  • Healthcare and pharmaceutical procurement

  • Market access and regulatory affairs

  • Patient advocacy and healthcare organisations

  • Pharmaceutical distribution and international sourcing

World Orphan Drug Congress 2026 — Event Details

Event: World Orphan Drug Congress (WODC) Europe 2026

Dates: 26–28 October 2026

Venue: RAI Amsterdam Convention Centre, Hall 10

Address: Europaplein 24, 1078 GZ Amsterdam, Netherlands

Organiser: Terrapinn

Please refer to the official event organiser for the latest agenda, registration details, and event updates.

Connect with IKRIS Pharma Network

Explore IKRIS Pharma Network’s exhibitor listing for World Orphan Drug Congress (WODC) Europe 2026 and view the available company information.

View IKRIS Pharma Network’s Exhibitor Profile →

About The Indian Pharma

The Indian Pharma is a pharmaceutical sourcing and export platform connected with IKRIS Pharma Network. The platform focuses on connecting international pharmaceutical buyers with medicine-sourcing and export-related information.

Frequently Asked Questions

What is the World Orphan Drug Congress (WODC) 2026?

The World Orphan Drug Congress Europe 2026 is an international event focused on rare diseases and orphan drug development, bringing together pharmaceutical and biotechnology professionals, researchers, patient organisations, and other industry stakeholders.

2. When and where is WODC Europe 2026 taking place?

WODC Europe 2026 is scheduled for 26–28 October 2026 at RAI Amsterdam Convention Centre, Hall 10, Europaplein 24, 1078 GZ Amsterdam, Netherlands.

3. What topics will be covered at the World Orphan Drug Congress 2026?

Key topics include orphan drug development, rare disease research, cell and gene therapies, genetic testing, precision medicine, clinical development, real-world evidence, market access, and patient advocacy.

4. Who should attend the World Orphan Drug Congress Europe 2026?

The event is relevant to pharmaceutical and biotechnology companies, rare disease researchers, clinical development teams, healthcare professionals, patient advocacy groups, regulators, investors, and market access specialists.

5. How can I view IKRIS Pharma Network’s exhibitor profile for WODC 2026?

You can view IKRIS Pharma Network’s exhibitor listing through the official Terrapinn website to access the available company and event information.

Nitin Goswami

Nitin Goswami is a pharmaceutical content writer and healthcare research editor at The Indian Pharma, focusing on pharmaceutical medicines, generic drugs, specialty medicines, medicine sourcing, global pharmaceutical markets, and patient-access programs. He develops and reviews healthcare content to make complex pharmaceutical information clear, practical, and easy to understand for patients, healthcare professionals, pharmaceutical companies, importers, distributors, and institutional buyers. His editorial work covers generic medicine supply, pharmaceutical exports, Named Patient Programs, unregistered and hard-to-source medicines, specialty therapies, regulatory considerations, and international medicine access. He focuses on responsible healthcare communication, factual accuracy, transparent sourcing information, and content supported by reliable pharmaceutical and regulatory references where applicable.

Related Articles

Click to Chat